Search Results for: EXECUTIVE INTERVIEW The Integration of


March 3, 2014

EXECUTIVE INTERVIEW – Gerresheimer: Understanding Customer Requirements March 3, 2014

Drug Development Executive: Andreas Schütte, Member of the Management Board, Plastics & Devices Division, discusses his important role in Gerresheimer’s divisional restructuring process, and how he is convinced the new structure better reflects customer requirements.

January 31, 2013

2/6/2013 January 31, 2013

Foresite Capital Closes $100 Million Fund for Late-Stage Biotechs Biotech venture capital isn't what it used to be, but there's...
November 19, 2012

11/21/2012 November 19, 2012

Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
October 1, 2012

10/3/2012 October 1, 2012

Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a...
July 30, 2012

8/1/2012 July 30, 2012

BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall...